Loading company…
MedWatch Technologies combines biosensing and AI coaching for non-invasive metabolic health monitoring.
MedWatch Technologies is developing a platform that combines biosensing with AI coaching to support real-time health monitoring, particularly for metabolic health. Its products are in development and pending FDA clearance. Co-founded in 2022, the company is based in Nevada, US. In January 2026, it raised USD 15 mn in Series A funding led by Stead Impact Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in